ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma.
ENGAGE-501:恩替诺司他(SNDX-275)治疗复发和难治性霍奇金淋巴瘤的 II 期研究
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2016.142406
Batlevi Connie Lee, Kasamon Yvette, Bociek R Gregory, Lee Peter, Gore Lia, Copeland Amanda, Sorensen Rachel, Ordentlich Peter, Cruickshank Scott, Kunkel Lori, Buglio Daniela, Hernandez-Ilizaliturri Francisco, Younes Anas